What Is GOAL.MD?
GOAL.MD runs three distinct offerings, and understanding which one you want matters more here than at most platforms. The compounded route starts at $149 for a first month with $50 off, then moves to standard monthly pricing — $199 for semaglutide and $249 for tirzepatide at the published rates.
The second offering is the interesting one. GOAL.MD's brand-name access programme charges $95 a month for physician evaluation and prescribing of brand-name semaglutide or tirzepatide, with a $45 first month. You buy the clinical relationship, not the drug, and then obtain FDA-approved medication through manufacturer or pharmacy channels. For patients who want brand-name medication without paying a telehealth markup on it, that is a genuinely well-designed product.
The third is Synergy — a dual-pathway protocol combining compounded semaglutide and tirzepatide, priced at a flat $597 a month for all dosages, or $547 with a three-month bundle. Medications are described as coming from FDA-registered 503A and 503B pharmacies. That is expensive, and the evidence base for combining both molecules is thinner than for either alone.
GOAL.MD also advertises no auto-billing, which in a category built on silent recurring charges is worth noting.
How GOAL.MD Works
- 1
Choose your pathway
Compounded GLP-1s, the $95 brand-name access programme, or the Synergy dual-pathway protocol. These are meaningfully different products at very different price points.
- 2
Physician evaluation
GOAL.MD emphasises physician supervision across all tiers rather than purely asynchronous mid-level review.
- 3
First-month discount applied
New patients receive $50 off their first month — $149 for compounded semaglutide, $249 for compounded tirzepatide, or $45 on the brand access programme.
- 4
Prescription and fulfilment
Compounded medication ships from FDA-registered 503A and 503B pharmacies. On the brand access programme, prescriptions route to manufacturer or retail channels where you pay for the drug separately.
- 5
Ongoing monthly care
Standard monthly pricing applies after the first month, with no auto-billing according to the platform's own materials.
Medications & Pricing
What GOAL.MD offers and the prices advertised at the time of this review.
| Medication | Format | Advertised price | Notes |
|---|---|---|---|
| Compounded semaglutide | Weekly injection | $149 first month, then $199 | $50 off applied to the first month for new patients |
| Compounded tirzepatide | Weekly injection | $249 first month, then higher | Standard monthly pricing applies thereafter |
| Brand-name access programme | Physician care only | $45 first month, then $95/mo | Covers evaluation and prescribing; medication billed separately |
| GLP-1 Synergy | Semaglutide + tirzepatide | $597/mo flat, $547 on 3-month | Flat across all dosages; from 503A and 503B pharmacies |
| Auto-billing | None advertised | $0 | Platform states no auto-billing |
GOAL.MD's three tiers serve different needs at very different prices. The $95 brand access programme covers physician care only — you pay for the medication separately through manufacturer or pharmacy channels, so budget both line items together.Pricing changes frequently across the GLP-1 market — always confirm the current cost on the provider's own site before enrolling.
Key Features
$95/month brand-name access
Paying for physician care rather than marked-up medication is a smart structure for patients who want FDA-approved drugs at manufacturer self-pay prices.
Physician supervision emphasised
Physician-led evaluation across tiers rather than purely asynchronous mid-level review, which matters for patients with more complex histories.
503A and 503B pharmacies named
Specifying FDA-registered facility types is more disclosure than most compounded platforms offer about their supply chain.
No auto-billing
In a market built on silent recurring charges, explicitly disclaiming auto-billing is a meaningful patient protection.
Consistent first-month discounts
$50 off across tiers lowers the cost of finding out whether a given pathway works for you.
Dual-pathway Synergy option
Combining both molecules at a flat rate across all doses is unusual, and available for patients who have plateaued on either alone.
GOAL.MD and Food Noise
The $95 brand access programme is the most food-noise-relevant thing GOAL.MD offers, for a reason that is easy to overlook. Dose consistency matters enormously for identifying the threshold at which intrusive food thoughts stop — with brand-name medication, a 7.5 mg dose is a 7.5 mg dose every time, so a plateau is unambiguous.
Paying $95 for physician care and then buying Zepbound at manufacturer self-pay prices frequently costs less in total than a compounded platform charging $250 all-in, while giving you a product with no sourcing questions attached. Run that arithmetic before assuming compounded is cheaper.
The Synergy protocol deserves a cautious note. Combining semaglutide and tirzepatide is not a standard clinical approach, and the evidence for it is considerably thinner than for either molecule alone. At $597 a month it is also the most expensive option here. For a patient who has genuinely plateaued at a maximum tirzepatide dose it may be worth discussing; it is not a sensible starting point.
There is no coaching or behavioural programme at any tier, so the work that follows appetite change is yours to arrange.
If the constant mental chatter about food is your main reason for seeking treatment, read our primer on what food noise actually is and how GLP-1 medications quiet it.
What GOAL.MD Patients Say
Composite patient accounts illustrating experiences commonly reported by people using GOAL.MD for GLP-1 medication management. Names are illustrative and individual results vary.
Roland V.
Brand-name Zepbound via GOAL.MD access programme · 8 months
The $95 access programme is the smartest thing I found in this whole market. I pay GOAL.MD for the doctor and buy real Zepbound direct from the manufacturer. Total cost is less than the compounded platform I left, and I know exactly what's in the vial. Food noise stopped completely by month three.
Cassidy N.
Compounded semaglutide via GOAL.MD · 5 months
$149 for the first month then $199 is fair, and I appreciated that they say outright there's no auto-billing — I've been caught by that elsewhere. My physician was thorough rather than rubber-stamping. Appetite chatter substantially down. No coaching at all, which I knew going in.
Prentice B.
GLP-1 Synergy via GOAL.MD · 6 months
I'd genuinely plateaued at maximum tirzepatide and my food noise had crept back. Synergy has worked for me — the chatter is quiet again. But it's $597 a month and I'd caution anyone that combining both molecules isn't a standard approach and the evidence is thin. Discuss it properly rather than jumping to it.
Delia M.
Compounded tirzepatide via GOAL.MD · 4 months
Naming the pharmacy types — 503A and 503B, FDA-registered — was more than my last two providers would tell me, and it made me more comfortable dosing properly rather than rationing. Food noise noticeably better. Pricing steps up after the first month, so budget from the standard rate.
Owen T.
Brand-name semaglutide via GOAL.MD access programme · 7 months
Buying care and medication separately turned out cheaper and cleaner than a bundled compounded plan. It does mean managing two transactions rather than one, which some people won't want. My appetite noise is much quieter and I have no anxiety about sourcing.
Who GOAL.MD Is Right For
A good fit if you
- ✓Want brand-name medication without paying a telehealth markup on it
- ✓Value physician supervision over asynchronous mid-level review
- ✓Want disclosure about the type of pharmacy compounding your medication
- ✓Object to auto-billing and silent recurring charges
- ✓Have genuinely plateaued and want to discuss a dual-pathway option
Look elsewhere if you
- →Want one bundled price covering care and medication together
- →Are looking for the lowest compounded monthly rate
- →Want coaching or behavioural support
- →Would consider the Synergy tier without having plateaued first
- →Want to use insurance
Pros & Cons
Pros
- +$95/month brand access programme is unusually well designed
- +Physician supervision emphasised across tiers
- +503A and 503B pharmacy types disclosed
- +No auto-billing, stated explicitly
- +Consistent $50 first-month discounts
- +Flat Synergy pricing across all dosages
Cons
- -Brand access means managing two separate costs
- -Compounded pricing steps up after the first month
- -Synergy at $597/month is expensive with a thin evidence base
- -No coaching or behavioural support at any tier
- -Three-tier structure takes effort to navigate
Frequently Asked Questions
How much does GOAL.MD cost?+
Compounded GLP-1s start at $149 for a first month with $50 off, then $199 for semaglutide and $249 for tirzepatide. The brand-name access programme is $45 for the first month then $95 a month for physician care only. GLP-1 Synergy is a flat $597 a month, or $547 with a three-month bundle.
What is the $95 brand access programme?+
You pay GOAL.MD for physician evaluation and prescribing of brand-name semaglutide or tirzepatide, then obtain the medication separately through manufacturer or pharmacy channels. It separates care from drug markup, which frequently produces a lower total than a bundled compounded plan.
What is GLP-1 Synergy?+
A dual-pathway protocol combining compounded semaglutide and tirzepatide at a flat $597 a month across all dosages, sourced from FDA-registered 503A and 503B pharmacies. Combining both molecules is not a standard clinical approach and the evidence is thinner than for either alone.
Is there auto-billing?+
GOAL.MD states there is no auto-billing, which is a meaningful protection in a category where silent recurring charges are common. Confirm the terms at checkout for the specific tier you choose.
Which pharmacies does GOAL.MD use?+
It describes sourcing from FDA-registered 503A and 503B pharmacies. Specifying facility type is more disclosure than most compounded platforms provide, though naming the specific pharmacy would be better still.
Should I consider Synergy?+
Only after genuinely plateauing at a maximum dose of a single molecule, and only after a proper clinical discussion. At $597 a month with a thin evidence base for combining both drugs, it is not a sensible starting point.
Our Verdict
GOAL.MD's $95 brand-name access programme is one of the better-designed products in this entire market, and it deserves more attention than it gets. Paying a physician for care and buying FDA-approved medication at manufacturer self-pay prices frequently costs less in total than a bundled compounded plan — and it gives you dose consistency, which is precisely what you need to identify the threshold where food noise stops. Add explicit disclosure of 503A and 503B sourcing and a stated no-auto-billing policy, and this is a platform behaving better than most. The Synergy tier is the part to approach carefully: at $597 a month, combining both molecules is expensive and thinly evidenced, and it belongs in a conversation about genuine plateau rather than at the start of treatment.
Visit GOAL.MDHow does GOAL.MD compare?
We have reviewed 167 GLP-1 providers. See where this one lands against the rest:
Continue Reading
This review is editorial content, not medical advice. Food Noise Stop is not affiliated with GOAL.MD. GLP-1 medications require a prescription and clinical supervision — talk to a licensed clinician about whether treatment is appropriate for you. See our medical disclaimer and affiliate disclosure.